MedPath

Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment

Not Applicable
Completed
Conditions
Cryotherapy Effect
Warts
Interventions
Device: EndWarts® FREEZE
Device: Liquid nitrogen
Registration Number
NCT04781244
Lead Sponsor
Mahidol University
Brief Summary

This study aimed to study cost-effectiveness of EndWarts® FREEZE for wart treatment, compared to conventional liquid nitrogen cryotherapy

Detailed Description

Cutaneous warts, caused by Human papilloma virus (HPV), are common skin disease. The prevalence reported in primary school children are 2-20%, and even higher in adults. Non-intact skin are prone to the infection, with all parts of the body can be affected. Even warts are not malignant, they can cause lack of confidence or affected patients' quality of life.

Nowadays there are many treatment methods for warts, such as topical application with salicylic acid and electrical cauterization. Cryotherapy with liquid nitrogen has been the therapy of choice due to its clinical effectiveness, which reported for 6-65%. Treatment mechanism in cryotherapy relies on in-depth freezing of infected keratocyte.

EndWarts® FREEZE is alternative home treatment cryotherapy device containing nitrous oxide. Recent clinical study found that it delivers significant result with good tolerability, and is user friendly. As for our knowledge, no study has been reported about cost-effectiveness of this device, so this study was designed to demonstrate the efficacy of this product in cutaneous warts.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Diagnosis of plantar or common wart at Department of Dermatology, Siriraj hospital
Exclusion Criteria
  • Patient with more than 5 warts or wart more than 1 cm in diameter
  • Wart at face, genitalia, scalp, joint
  • Pregnancy or breastfeeding patient
  • Wart with wound/irritation or local infection
  • Diabetes mellitus patients or patients with coagulopathies or cryoglobulinemia
  • Immunocompromised host or on immunosuppressive drug
  • Received any treatment in previous 3 months before inclusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EndWarts® FREEZE in Hard keratinEndWarts® FREEZEEndWarts® FREEZE were treated to 11 patients with wart at hard keratin
EndWarts® FREEZE in Soft keratinEndWarts® FREEZEEndWarts® FREEZE were treated to 11 patients with wart at soft keratin
Liquid nitrogen in Hard keratinLiquid nitrogenLiquid nitrogen were treated to 11 patients with wart at hard keratin
Liquid nitrogen in Soft keratinLiquid nitrogenLiquid nitrogen were treated to 11 patients with wart at soft keratin
Primary Outcome Measures
NameTimeMethod
Cost-effectiveness of EndWarts® FREEZE12 weeks

Evaluate cost-effectiveness of EndWarts® FREEZE for wart treatment compared with conventional liquid nitrogen therapy. Transportation fee to the hospital, medical and doctor fee are recorded to sum up the costs of treatment at every visit. Every patient is also required to have his/her wart examined by the same physician at each visit with the use of dermoscope to evaluate the result of wart treatment (worse, the same, partial response, complete response). Moreover, wart size is measured for its diameter and height, then photographed at each visit to recorded the change after treatment. Cure rates will be shown according to type of intervention received, with the use of chi-square test.

Secondary Outcome Measures
NameTimeMethod
Compared Dermatology quality of life index before and after treatment12 weeks

Compared patient's Dermatology quality of life index (DLQI) between treatment of EndWarts® FREEZE and liquid nitrogen. DLQI is recorded before the treatment start and after 12-week treatment (or before 12 week if the patient's wart is cured completely). Change in DLQI will be shown with descriptive statistics.

Trial Locations

Locations (1)

Department of Dermatology, Siriraj Hospital Mahidol University

🇹🇭

Bangkok Noi, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath